Evidence map›Paper›PMID 34870582›Full record

ArticleJournal of medical microbiology2021

Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing

Silje N Ramstad, Lin T Brandal, Arne M Taxt, Yngvild Wasteson, Jørgen V Bjørnholt, Umaer Naseer

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Inhibition of Shiga Toxin 2 forCurrent medicinal chemistry · 2026
    Article
  3. Article
  4. Article
  5. Transforming Shiga toxin-producingFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Silje N RamstadDepartment of Microbiology, Division of Laboratory Medicine, Oslo University Hospital, PB 4956 Nydalen, 0424 Oslo, Norway.
Lin T BrandalDepartment of Infectious Diseases and Prevention, Norwegian Institute of Public Health, Oslo, Norway.
Arne M TaxtDepartment of Microbiology, Division of Laboratory Medicine, Oslo University Hospital, PB 4956 Nydalen, 0424 Oslo, Norway.
Yngvild WastesonDepartment of Paraclinical Sciences, Norwegian University of Life Sciences, Oslo, Norway.
Jørgen V BjørnholtDepartment of Microbiology, Division of Laboratory Medicine, Oslo University Hospital, PB 4956 Nydalen, 0424 Oslo, Norway.
Umaer NaseerDepartment of Infectious Diseases and Prevention, Norwegian Institute of Public Health, Oslo, Norway.
Oslo University Hospital · NONorwegian Institute of Public Health · NONorwegian University of Life Sciences · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialShiga-Toxigenic Escherichia coliGenotypeHumansMultilocus Sequence TypingNorwayPhylogenyPrevalenceAnti-Bacterial Agentsantimicrobialsantimicrobial treatmentgenotypic resistance determinantsShiga toxin-producing Escherichia coliwhole-genome sequencing

Identifiers

PMID34870582
PMCPMC8744279
OpenAlexW4200426886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.